HAL (France)
open access
Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory Failure#1185572
- Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study#1152703
- Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients#1056980
- Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study#839270
- Study of Viral Respiratory Infections#877971
Record · ID 1235736
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive